M&B Engineering IPO to Open on July 30; Check Price Band, Lot Size, and More

M&B Engineering Ltd, a Gujarat-based leader in pre-engineered buildings (PEBs) and self-supported steel roofing solutions, is set to launch its ?650 crore initial public offering (IPO). The IPO opening date is July 30, 2025. The IPO will close on August 1, 2025, with the shares expected to list on the BSE and NSE on August 6, 2025.?

Offer Details

Price Band: The IPO price band is set at ?366 to ?385 per share.?

Listing: The equity shares are proposed to be listed on NSE and BSE.?

Lot Size:

• For retail investors: 1 lot (38 shares), requiring a minimum investment of ?13,908.
• For Non-Institutional Investors (NIIs)
  • sNII (small NII): Minimum application of 14 lots (532 shares), requiring an investment of ?2,04,820
  • bNII (big NII): Minimum application of 69 lots (2,622 shares), requiring an investment of ?10,09,470.
• Book-running lead manager: Equirus Capital Private Limited and DAM Capital Advisors Limited
• Registrar: MUFG Intime India Private Limited
• Use of Proceeds: The net proceeds from the fresh issue will be utilised to -??
• • Fund capital expenditures related to the acquisition of machinery, equipment, building improvements, solar rooftop grid installations, and transportation vehicles at the company’s manufacturing facilities
  • Upgrading and enhancing company’s information technology (“IT”) software systems
  • Repay/prepay outstanding borrowings
  • For general corporate and operational purposes.

Check out newly Listed IPOs on BSE and NSE.

About the company

Established in 1981, M&B Engineering specialises in the design, manufacturing, and installation of PEBs and steel roofing systems. The company operates two manufacturing facilities in Gujarat and Tamil Nadu, with a combined capacity of 103,800 metric tonnes per annum for PEBs and 1.8 million square meters per annum for roofing solutions.?

Explore other Upcoming IPOs on BSE and NSE.

Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.

To read the RA disclaimer, please click here